tm logo

Monitor this mark

View On USPTO

KBI BIOPHARMA
Live/Registered
REGISTERED AND RENEWED

on 16 Dec 2022

Last Applicant/ Owned by

KBI Biopharma, Inc.

1101 Hamlin Road

Durham

NC

27704

Serial Number

85566501 filed on 12th Mar 2012

Registration Number

4340914 registered on 28th May 2013

in the Principal Register

Correspondent Address

F. Michael Sajovec

F. Michael Sajovec

Williams Mullen Center

200 South 10th Street, Suite 1600

Richmond VA 23219

Filing Basis

1. use application currently

Disclaimer

NO DATA

KBI BIOPHARMA

contract manufacturing in the field of biopharmaceuticals contract biopharmaceutical drug development services

Classification Information

Class [040]
Treatment & Processing of Materials Services

contract manufacturing in the field of biopharmaceuticals

First Use Date in General

31st Dec 2001

First Use Date in Commerce

31st Dec 2001

Class [042]
Computer & Software Services & Scientific Services

contract biopharmaceutical drug development services

First Use Date in General

31st Dec 2001

First Use Date in Commerce

31st Dec 2001

Mark Details

Serial Number

No 85566501

Mark Type

No Service Mark

Attorney Docket Number

No 077489.0010

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
16th Dec 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
16th Dec 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16th Dec 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
15th Dec 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Jun 2022TEAS SECTION 8 & 9 RECEIVED
28th May 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Jul 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06th Jul 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06th Jul 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28th May 2019TEAS SECTION 8 & 15 RECEIVED